Suppr超能文献

培养的人系膜细胞可产生1型和2型纤溶酶原激活物抑制剂。

Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.

作者信息

Colucci M, Gesualdo L, Montemurro P, Cavallo L G, Conese M, Mascolo E, Ranieri E, Di Paolo S, Schena F P, Semeraro N

机构信息

Dipartimento di Scienze Biomediche e Oncologia Umana, Università di Bari, Italy.

出版信息

Thromb Haemost. 1995 Dec;74(6):1516-20.

PMID:8772230
Abstract

Cultured human mesangial cells (HMC) derived from normal kidneys have been shown to synthesize tissue-type plasminogen activator (t-PA) and excess amounts of PA inhibitor type 1 (PAI-1). Conflicting results have been obtained concerning the production of urokinase-type PA (u-PA) and efforts to show PA inhibitor 2 (PAI-2) met with failure. We evaluated the fibrinolytic profile of cultured HMC lines obtained from 12 patients with renal carcinoma and one cadaveric kidney donor. Subconfluent cells (third passage) were incubated overnight in serum-free medium. t-PA, u-PA, PAI-1 and PAI-2 antigens were assayed by ELISA methods and PA and PAI activities by amidolytic methods both in conditioned medium (CM) and cell extracts (CE). Besides PAI-1, PAI-2 antigen was detected in all but one HMC lines. At variance with the former, which was largely released in the culture medium, PAI-2 was mainly cell-associated. t-PA antigen was found in all but two cell lines while u-PA antigen was detected in relatively high concentrations in 8 cell lines. PA activity, identified as u-PA by functional and immunological criteria, was measured in CM of six of the eight u-PA producing cell lines, whereas PAI activity was undetectable or very low in CM of all cell lines, suggesting that PAI-1 was largely inactive. Functional assays of cell extracts demonstrated the presence of PA activity, again identified as u-PA, only in samples (five lines) containing u-PA antigen in excess over PAI-2. PAI activity was found instead in the extracts in which the inhibitor was higher than the activator (six lines) and was identified as PAI-2, as it inhibited u-PA but not single-chain t-PA and was neutralized by a polyclonal anti-PAI-2 antibody. The heterogeneous fibrinolytic pattern of HMC lines was confirmed by mRNA analysis of three representative lines. Results were similar when HMC lines at passage five were used, except that the u-PA content was significantly reduced both in CM and CE. These findings indicate that the fibrinolytic profile of cultured HMC is more complex than previously reported. The production of large amounts of PAI-2 may represent an additional control mechanism of proteinase activity.

摘要

来自正常肾脏的培养人系膜细胞(HMC)已被证明能合成组织型纤溶酶原激活物(t-PA)和过量的1型PA抑制剂(PAI-1)。关于尿激酶型PA(u-PA)的产生,研究结果相互矛盾,而检测PA抑制剂2(PAI-2)的努力也以失败告终。我们评估了从12例肾癌患者和1名尸体肾脏供体获得的培养HMC系的纤溶特性。亚汇合细胞(第三代)在无血清培养基中孵育过夜。通过ELISA方法检测t-PA、u-PA、PAI-1和PAI-2抗原,并通过酰胺分解法检测条件培养基(CM)和细胞提取物(CE)中的PA和PAI活性。除了PAI-1外,在所有HMC系中均检测到PAI-2抗原,但有一个系除外。与大量释放到培养基中的PAI-1不同,PAI-2主要与细胞相关。除了两个细胞系外,在所有细胞系中均发现了t-PA抗原,而在8个细胞系中检测到相对高浓度的u-PA抗原。通过功能和免疫标准鉴定为u-PA的PA活性,在8个产生u-PA的细胞系中的6个细胞系的CM中进行了测量,而在所有细胞系的CM中均未检测到或检测到非常低的PAI活性,这表明PAI-1在很大程度上没有活性。细胞提取物的功能分析表明,仅在u-PA抗原含量超过PAI-2的样品(5个细胞系)中存在PA活性,同样鉴定为u-PA。相反,在抑制剂高于激活剂的提取物(6个细胞系)中发现了PAI活性,并鉴定为PAI-2,因为它抑制u-PA但不抑制单链t-PA,并且被多克隆抗PAI-2抗体中和。通过对三个代表性细胞系的mRNA分析,证实了HMC系的异质纤溶模式。当使用第五代HMC系时,结果相似,只是CM和CE中的u-PA含量均显著降低。这些发现表明,培养的HMC的纤溶特性比以前报道的更为复杂。大量PAI-2的产生可能代表了蛋白酶活性的另一种控制机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验